This has helped create a niche in the industry,which has spearheaded our rapid sales. Cyanide is believed to be cytotoxic with actions selective against cancerous cells, but results from animal studies were mostly negative. have been created after extensive research, dedicated expert manpower, thorough and stringent clinical trials. Many of Troikaa’s products like Parenteral Emulsions (Propofol Etomidate injection), inhalation agents for anaesthesia (Isoflurane, Sevoflurane), Sublingual Tablets, etc. B) Strong Portfolio of Difficult to Manufacture Products: If that is not available, sodium thiosulfate may be used alone. If cyanide toxicity develops concurrent with carbon monoxide poisoning (e.g., closed space fire), hydroxocobalamin is the preferred antidote. It may affect our short-term profitability but it drives long-term growth.Our R&D innovations have helped steer us into global markets and made us a well-recognized company worldwide. 1) Treatment should not be delayed for laboratory results if a cyanide exposure is strongly suspected. This approach has helped us in creating path-breaking brands.Įach patentedbrand at Troikaa has stemmed from original innovations of which the lead time from concept to commercialization has been effectively maintained from 6 to 10 years. Our R&D Department is approved by the Department of Scientific & Industrial Research, Government of India and has an innovation-driven approach. A) Strong portfolio of Patented Innovations:
0 Comments
Leave a Reply. |